Pharmafile Logo

Delivering change through better rare disease communications

February 28, 2020 |  

OPEN Health’s Richard Jones, Gemma Allen and Charlotte Richards discuss how pharma can utilise tools, channels and stakeholders to deliver change and enable better outcomes.

Many innovative therapies are being launched in rare disease following years of research that has been driven by the emergence of new technology and regulatory incentives. This brings high levels of hope and expectation to the rare disease community. Consequently, it’s vital that biotechnology and pharmaceutical companies cut through the noise to bring real understanding and informed decision making about the next generation of orphan drugs. Doing this requires communications that encompass the right mix of tools, methodologies, channels and people.

EXPLORING THE CHALLENGES IN RARE DISEASE THROUGH BETTER COMMUNICATION STRATEGIES

OPEN Health recognises that there are multiple challenges in commercialising new therapies in rare disease and is leading future practice in communications by placing emphasis on a ‘patient first’ approach. This includes supporting Benjamin James’s recent analysis on what the future could look like for outcomes driven communications in this space. Benjamin is a trustee and patient advocate for DMD Pathfinders and has recently completed a Masters in Scientific Communications. This provides us with a valued perspective on how improvements can be made for the benefit of patients. A summary of his findings can be found here.

To read the full article click here.

Pink divider

Get in touch

For more information on our commitment to better outcomes in rare disease please contact:

Gavin Jones, Director of Rare Disease, OPEN Health

Gavinjones@openhealthgroup.com

This content was provided by OPEN Health

Company Details

 Latest Content from  OPEN Health 

OPEN Health Appoints Matt D’Auria as Chief Executive Officer to Drive Innovation and Growth

OPEN Health Group is pleased to announce the appointment of Matt D’Auria as its new Chief Executive Officer (CEO). Based in the US, Matt brings more than 25 years of...

OPEN Health Appoints David Sakadelis as Chief Technology Officer

OPEN Health is pleased to announce the appointment of David Sakadelis as Chief Technology Officer. In this role, David will be responsible for enhancing our services through technology-enabled solutions for...

The Potential Impact of the New Presidential Administration on the Future of the Inflation Reduction Act and Broader Healthcare Policy

Discover the key takeaways from OPEN Health’s latest whitepaper: "The Potential Impact of the New Presidential Administration on the Future of the Inflation Reduction Act and Broader Healthcare Policy."

OPEN Health Presents First Collection of Research Backed by Scientific Buyout Fund to Foster Research and Development

OPEN Health is excited to announce the upcoming presentation of a collection of research supported by its Scientific Buyout Program. This initiative empowers our team members to dedicate time toward...

OPEN Health and fusion announce partnership to deliver AI-powered healthcare communications

OPEN Health, a pre-eminent global provider of scientific communications, HEOR and market access, patient engagement, and consulting, today announced a partnership with fusion, an innovative artificial intelligence (AI) and machine...

OPEN X Health launches to provide data-driven creativity to the pharmaceutical industry

OPEN X Health launches to provide data-driven creativity to the pharmaceutical industry

OPEN Health Appoints Steven Duryee as Chief Operating and Transformation Officer

OPEN Health Appoints Steven Duryee as Chief Operating and Transformation Officer

Unlock possibilities: A Medical Affairs strategy fit for the future

Explore the key areas to include in a Medical Affairs strategy and plan that is fit for the future in our latest whitepaper.

OPEN Health and Nested Knowledge announce strategic research collaboration to leverage AI technologies for evidence synthesis

OPEN Health and Nested Knowledge announce strategic research collaboration to leverage AI technologies for evidence synthesis

OPEN Health unites patient engagement experts to transform the patient experience

OPEN Health, a preeminent global provider of consulting, HEOR and market access, patient engagement, and scientific and creative communications services, is bringing together experts in strategic patient innovation and engagement,...